Equities

Roivant Sciences Ltd

Roivant Sciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)12.39
  • Today's Change0.57 / 4.82%
  • Shares traded7.72m
  • 1 Year change+37.67%
  • Beta1.2324
Data delayed at least 15 minutes, as of Nov 22 2024 20:14 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1256155
OPERATING EXPENSES
Cost of revenue total16138.97
Selling, general and admin. expenses, total687601425
Depreciation/amortization------
Unusual expense(income)(5355)68418
Other operating expenses, total------
Total operating expense(4150)1,2071,335
Operating income4,275(1146)(1280)
Other, net(85)(62)6.59
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes4,253(1225)(924)
Provision for income taxes225.190.37
Net income after taxes4,231(1230)(924)
Minority interest11810679
Net income before extra. Items4,349(1124)(845)
Total extraordinary items0115--
Net income4,349(1009)(845)
Inc.avail. to common excl. extra. Items4,349(1124)(845)
Inc.avail. to common incl. extra. Items4,349(1009)(845)
EPS RECONCILIATION
Basic/primary weighted average shares783713670
Basic/primary eps excl. extra items5.55(1.58)(1.26)
Basic/primary eps incl. extra items5.55(1.42)(1.26)
Dilution adjustment------
Diluted weighted average shares831713670
Diluted eps excl. extra items5.23(1.58)(1.26)
Diluted eps incl. extra items5.23(1.42)(1.26)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue----0
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental35287.04
SUPPLEMENTAL INCOME
Depreciation, supplemental1211--
Total special items(5381)(29)418
NORMALISED INCOME
Normalized income before taxes(1128)(1254)(505)
Effect of special items on income taxes(1883)(10)97
Income tax excluding impact of special items(1861)(5.06)98
Normalized income after tax733(1249)(603)
Normalized income avail. to common851(1143)(524)
Basic normalized EPS1.09(1.6)(0.78)
Diluted normalized EPS1.02(1.6)(0.78)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.